DEVELOPMENTAL FUNDS

$120,473P30FY2014CANIH

Oregon Health & Science University, Portland OR

Investigators

Linked publications, trials & patents

Paper 39764100 Paper 39763867 Paper 39605535 Paper 39435649 Paper 39386578 Paper 39375962 Trial NCT07434128 Trial NCT07278440 Trial NCT07089940 Trial NCT05705492 Trial NCT04247425 Trial NCT04172493 Trial NCT04104139 Trial NCT04061980 Trial NCT04005690 Trial NCT03961672 Trial NCT03960177 Trial NCT03699995 Trial NCT03677531 Trial NCT03649880 Trial NCT03626285 Trial NCT03613259 Trial NCT03544125 Trial NCT03479268 Trial NCT03418025 Trial NCT03406013 Trial NCT03361436 Trial NCT03347617 Trial NCT03325166 Trial NCT03280277 Trial NCT03270059 Trial NCT03261180 Trial NCT03234309 Trial NCT03135782 Trial NCT03097588 Trial NCT03028935 Trial NCT03010358 Trial NCT03009201 Trial NCT02890979 Trial NCT02869412 Trial NCT02857218 Trial NCT02779283 Trial NCT02736617 Trial NCT02522715 Trial NCT02504359 Trial NCT02503358 Trial NCT02501759 Trial NCT02498951 Trial NCT02427841 Trial NCT02359097 Trial NCT02355262 Trial NCT02312557 Trial NCT02228265 Trial NCT02100189 Trial NCT02099864 Trial NCT02092324 Trial NCT02070705 Trial NCT02050919 Trial NCT01913015 Trial NCT01748942 Trial NCT01689987 Trial NCT01649505 Trial NCT01635413 Trial NCT01620216 Trial NCT01532687 Trial NCT01498978 Trial NCT01441882 Trial NCT01422408 Trial NCT01253642 Trial NCT01031953 Trial NCT01005914 Trial NCT00983398 Trial NCT00978562 Trial NCT00900302 Trial NCT00900068 Trial NCT00900055 Trial NCT00899795 Trial NCT00899522 Trial NCT00843167 Trial NCT00822848 Trial NCT00764517 Trial NCT00722072 Trial NCT00691652 Trial NCT00662103 Trial NCT00660543 Trial NCT00659126 Trial NCT00627276 Trial NCT00516542 Trial NCT00482274 Trial NCT00425386 Trial NCT00324324 Trial NCT00303849 Trial NCT00293475 Trial NCT00253721 Trial NCT00253643 Trial NCT00238433 Trial NCT00227682 Trial NCT00103038 Trial NCT00075387 Patent 9279811

Abstract

PROJECT SUMMARY (See instructions): Developmental funds controlled by the Director are derive from institutional sources, including Knight Cancer Institute funds raised through the OHSU Foundation, contributions from the OHSU Hospital and Clinics and the School of Medicine, and the support from our CCSG. The Director has formal authority for all cancer related funds raised by the OHSU Foundation. The Knight Cancer Institute has used developmental funds from philanthropic sources as well as CCSG support to: recruit new faculty, support pilot projects, establish new Shared Resources, and provide support for technological and resource enhancements within the Shared Resources. In the last funding period, the OHSU development staff raised $33,000,000 in philanthropic contributions with an additional $98,000,000 gift that will be distributed over the next 5 - 7 years. Additionally, three endowed faculty positions have been established. The Knight has used CCSG funds, matched with philanthropic funds to support pilot projects, career development awards and bridge funding. The goal of this support has been to provide critical resources for cancer investigators to obtain preliminary funding for external peer-reviewed funding and to encourage innovative cancer research projects. A total of $668,000 of pilot project and career development award funding have been distributed over the past five years. These funds have contributed to over $20.9 million of external peer-reviewed funding. Development funds have been utilized to strengthen shared resources, as well as support women accruals to clinical trials. Over the past funding period shared resources have been invested in heavily to expand services offered, upgrade instrumentation, and ensure that sen/ices offered remain state-of-the art. To support accrual of women to clinical trials, funds were spent for recruitment of faculty specializing in female oncologic diseases, and infrastructure support for the Clinical Research Management Shared Resource.

View original record on NIH RePORTER →